Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix in Adults with Haematologic Malignancies
NCT01767467Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2013
- Primary completion
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 21
01
Overview
A Phase 3 trial of herpes zoster vaccine (recombinant, adjuvanted) in herpes zoster (HZ), sponsored by GSK. Started Mar 2013; status: completed.
02
Drugs
herpes zoster vaccine (recombinant, adjuvanted)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT01767467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767467.